It is not much to ask for that regulators require a watchlist to build, doesn't it?Building a watchlist is a requirement that regulators need, isn't it?
A supplier passes the qualification. The audits are satisfactory. Documentation is comprehensive. A few months later, the supplier gets a regulatory warning which has a negative impact on its production and deliveries.
This is a more frequent occurrence than many drug companies are aware of.
Supplier qualification is not an one-off process. The regulatory status may change anytime. New risks can emerge in the form of warning letters, import alerts, inspection results, and product recalls many months after a supplier has been accepted.
For this reason, many procurement, quality and regulatory teams have regulatory watchlists. A watchlist allows you to monitor key compliance indicators and pinpoint any potential issues before they become a problem in your supply chain.
Where your organization relies on a number of suppliers, a regulatory watchlist can be one of your most powerful risk management tools.
A structured approach for tracking suppliers, products, and manufacturing operations for regulatory events that could impact compliance, quality or continuity of supply is called a regulatory watchlist.
In contrast to the onboarding process, where companies only check supplier information, watchlists are tools used to check supplier information over time. It's all about the goal — catch risks early and act to prevent them from getting bigger.
Watchlist items may include inspection results, supplier names, warning letter, import alert, recalls and other regulatory data. This information is reviewed regularly by teams and actions will be taken if new risks arise.
Such a strategy helps to move compliance from reactive to proactive.
The pharmaceutical supply chain is becoming more global. In many cases a product relies on many suppliers from various countries with different regulatory requirements.
Regulatory agencies are also taking a closer look at data integrity, manufacturing controls, quality systems and patient safety at the same time.
A breach in compliance goes beyond that of the regulations. Shipments can get delayed, supplies can get cut short, extra audits, product shortages, and even a damage to the reputation of the business are all possibilities.
Most of these problems don't just develop overnight. Regulatory agencies may issue signals in the lead-up to a big action. By alerting these indicators, organizations have more time to evaluate risks and make decisions.
A regulatory watch list offers that visibility
Not all changes in regulations necessitate action. But some of these signals are worth careful consideration as they have the potential to impact the reliability of suppliers and product availability.
Warning letters signal that there are serious compliance issues. A warning letter is not an automatic prohibition on production, it does indicate that corrective actions are necessary.
Products may be barred from certain markets if an import alert is in effect. They are an early warning indicator for sourcing teams that their supplies may be affected.
The findings of inspection identify areas for improvement in manufacturing, quality systems or documentation. If repeated observations occur it can be a sign of more widespread compliance issues.
Recalls can also identify quality problems with products, factories or suppliers. Recall history tracking assists businesses to determine the performance of their suppliers over time.
Suspensions, consent decrees, restrictions and other enforcement actions can be an indicator of increased scrutiny and risk to businesses.
The intent of observing these signals is not to eliminate suppliers as quickly as possible. It is to be aware of any potential hazards and to decide if further inspection is required.
It doesn't take a complicated system to create a regulatory watchlist. The important thing is to establish a repeatable process.
Identify the suppliers and products that are critical to the project. Identify the critical suppliers and products for the project.
Avoid starting from the least desirable suppliers to your business first.
This includes:
Start with suppliers that would impact production or product availability.
Determine which regulatory events you want to track.
Common criteria include:
The criteria should match your organisation's risk profile.
All events are not equal in risk.
Create categories such as:
This helps teams to prioritize investigations and corrective actions.
A watchlist will only be effective if it is reviewed regularly.
Some do monthly reviews. Others check updates on high-risk suppliers on a weekly basis.
Select a schedule based on the supplier's importance and risk associated.
Teams must have a clear process for responding after a significant regulatory event.
Define:
If the ownership is not clear, significant updates may be missed.
Several common mistakes can cause this to be ineffective. Here are some common mistakes that can make this ineffective.
There are so many organizations that have been developing watchlists but they have a problem in maintaining them.
Common mistakes include:
A watchlist must be used to aid decision making. When it is hard to maintain and interpret, its value rapidly becomes low.
Manual monitoring is appropriate if you have only a few suppliers. As suppliers expand, it can get complicated.
Thousands of updates for regulations are published every year. It's a large job to keep track of several sources, check with suppliers, and keep accurate records.
Manual methods also pose the danger of missing out on updates and inconsistent assessments.
Centralized monitoring is a critical need as companies grow their supplier base.
The role of a pharma database in bolstering Regulatory monitoring.The importance of a Pharma Database in enhancing Regulatory monitoring.
A pharma database facilitates organizations in centralizing their supply chain intelligence and regulatory data.
Teams can check supplier profiles, compliance data, and regulatory updates in one place, rather than having to download from various sources.
This makes it easier to see and shorter the time needed for supplier due diligence.
A chemical pharma database will also enable the team to compare suppliers, view company data and continue their risk assessments.
It is not the objective to gather more data. The aim is to improve access and action on compliance information.
The Regulatory Watchlist Template contains the required data fields for the regulation watchlist.
A good watch list should contain:
Ensuring these fields are kept up to date establishes a uniform approach to supplier risk monitoring.
The regulatory monitoring landscape is constantly changing.
To gain better visibility, many organisations are now relying on automated alerts, centralised intelligence platforms and risk scoring models.
Unlike the traditional annual supplier audit, teams can monitor and detect significant regulatory developments as they happen.
This expedites the assessment and enables better decision-making.
It can be difficult to manage supplier and regulatory data from various sources.
Through the in-depth pharma database, Chemxpert enables companies to consolidate supplier intelligence, company data and regulatory information. This means procurement, quality and regulatory compliance teams can keep a more effective eye on suppliers, facilitate due diligence processes, and gain greater visibility into their supply chain.
Supplier Approval is not a panacea for regulatory risks. During a supplier relationship, new compliance issues, inspections, recalls and enforcement actions can present themselves.
A regulatory watchlist enables you to be aware and take action before they begin to impact operations.
You can enhance supplier oversight and mitigate avoidable risk by keeping an eye on some of the critical regulatory signals, having a structured review process and relying on reliable intelligence sources. It can help make that process much easier and effective for organizations that have large supplier networks.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!